Android app on Google Play

Buy Insulent Corp. (PODD) on Weakness - Canaccord Genuity

August 9, 2012 9:15 AM EDT Send to a Friend
Get Alerts PODD Hot Sheet
Price: $36.81 -0.11%

Rating Summary:
    12 Buy, 4 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 16 | Down: 12 | New: 33
Trade PODD Now!
Join SI Premium – FREE
Today Canaccord Genuity reiterated their Buy rating on Insulet Corporation (NASDAQ: PODD) but cut the price target to $24.50 (from $27.00).

"Strength in the core OmniPod business was very encouraging, but offset by weaker-than-expected results from NDI," said William J. Plovanic.

"Given the continued back-and-forth with the FDA, we are now modeling for Gen2 to gain FDA clearance by YE/12, pushing out an acceleration in growth and margin improvement into the Q2/13," he added.

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $18.72 yesterday.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity

Add Your Comment